-
Product Insights
Pancreatic Islet Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Pancreatic Islet Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Pancreatic Islet Transplant Rejection pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pancreatic Islet Transplant Rejection, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
-
Product Insights
Cutaneous Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Cutaneous Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Cutaneous Lupus Erythematosus pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cutaneous Lupus Erythematosus, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lupus Erythematosus pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lupus Erythematosus, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hereditary Angioedema (HAE) Pipeline Drugs Development Market Overview Hereditary Angioedema (HAE) is a rare inherited disease that causes considerable swelling in various body tissues, such as the abdomen or face. Symptoms include severe abdominal pain and cramping, dehydration, diarrhea and shock, hoarse voice, difficulty swallowing and difficulty breathing. Treatment includes medications, such as epinephrine, antihistamines, and corticosteroids. The Hereditary Angioedema pipeline drugs market research report provides comprehensive information on the therapeutics under development for Hereditary Angioedema, complete with analysis by...
-
Product Insights
Sicca Syndrome (Sjogren) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Sicca Syndrome or Sjogren's syndrome is an autoimmune disease. It involves inflammation of glands and other tissues of the body. Symptoms include skin rashes or dry skin, vaginal dryness, persistent dry cough, prolonged fatigue, dry eye, dry mouth, joint pain, swelling, and stiffness. Predisposing factors include age, sex, and rheumatic disease. The Sicca Syndrome pipeline drugs market research report provides comprehensive information on the therapeutics under development for Sicca Syndrome, complete with analysis by stage of development, drug target, mechanism...
-
Product Insights
Heart Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Heart transplantation is the therapy used in various heart diseases. Heart transplant replaces an injured or diseased heart with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Following a transplant, the immune system may consider the transplanted heart as foreign and may work against it. Patients may hence develop complications and eventually reject the new organ. Immunosuppressive drugs are administered simultaneously which prevent the body from either identifying or attacking the foreign organ...
-
Product Insights
Acute Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Acute Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Acute Inflammation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Inflammation, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Corneal Graft Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Corneal Graft Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Corneal Graft Rejection pipeline landscape. The report provides comprehensive information on the therapeutics under development for Corneal Graft Rejection, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics,...
-
Product Insights
Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Food Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Food Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Food Allergy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.